Melior Capital Management is a Swiss domiciled company investor and advisory firm focused exclusively on the global life-science sector.
We specialise in providing funding to medtech, biotech and pharmaceutical companies by applying institutional quality service and process to provide capital.
Our investment approach is to fund qualified innovative projects, with proven management teams, promising data, robust IP, strong corporate governance and a likely opportunity for significant commercial upside in the short to the medium term.
In the current environment, many existing companies seeking capital for medical trials have encountered a diminishing supply of funding from governments, private equity firms, investment banks and research foundations in favor of start-ups. At Melior, we combine the global reputation of our scientific, management, and advisory members to select best in class investment opportunities with credible upside potential.
Our value proposition is attributable to both our specialist world class team and their proven track record in the life-science sector, plus the strong emphasis that we place upon due diligence and first hand experience. Our goal is to offer attractive and diverse investments to both high net worth private clients and larger corporates through their professional advisers. For our business to be truly successful, we consider the needs of all parties, including our investees, investors and professional advisers at introduction and throughout the life of the investment. Our financial success is directly related to the financial return of all parties as we all share a common goal.
Melior does not accept enquiries from members of the general public, but we welcome enquiries from professional intermediaries.
What makes us different?
Successfully investing in the life-science sector requires an ability to navigate through, and take advantage of, the risks inherent in the sector.
Melior’s established market presence has enabled us to build strong relationships with leading MedTech, Biotech and Pharmaceutical companies. Our experience and relationships position Melior to identify industry trends, source compelling opportunities and patiently build unique businesses in a changing and evolving landscape.
We actively work with our investee companies to assess and manage risk, develop and execute business and financing plans and, ultimately, optimize exit strategies.